P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy

Human Pathology
Dariusz BorysAndrew Horvai

Abstract

Although pathologic response to neoadjuvant chemotherapy is highly correlated with survival among patients with osteosarcoma, there are currently no established molecular markers to predict response to chemotherapy. The objective of this study was to investigate the relationship of P16 expression in pretreatment osteosarcoma tumors to pathologic necrotic response after neoadjuvant chemotherapy. A tissue microarray was created from paraffin-embedded pretreatment biopsy specimens of 40 patients with osteosarcoma. Immunohistochemistry was performed with commercially available P16 monoclonal mouse antibody. Expression of P16 was defined as nuclear staining in 30% or greater of cells. Percent tumor necrosis was measured in postchemotherapy resection specimens per established protocols, and 90% or greater tumor necrosis was considered "good." Data were abstracted on age, sex, tumor site, and histologic subtype. Univariate and multivariate analyses were performed. The median age was 15 years, 52% were female, and 35% of tumors were located in the femur. P16 expression was present in 62%. Median posttreatment tumor necrosis was 90%, and 55% of patients experienced "good" chemotherapy response (≥90% necrosis). On univariate analysis, P1...Continue Reading

References

Jun 1, 1988·World Journal of Surgery·A G Huvos
Nov 23, 1995·The New England Journal of Medicine·N BaldiniM Campanacci
Jun 6, 1998·International Journal of Oncology·L MolendiniP Picci
Sep 30, 1999·International Journal of Cancer. Journal International Du Cancer·M S BenassiP Picci
Nov 24, 1999·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·N BaldiniM Campanacci
Mar 10, 2001·International Journal of Cancer. Journal International Du Cancer·A MaitraJ Geradts
Feb 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo SerraPiero Picci
Nov 7, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G BacciE S Ferrari
Feb 11, 2005·Pediatric Blood & Cancer·Shayna ZelcerRichard Gorlick
Aug 24, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gaetano BacciPiero Picci
Oct 26, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefano FerrariUNKNOWN Italian and Scandinavian Sarcoma Groups
Jul 16, 2009·Current Drug Targets·W Du, J S Searle
Oct 24, 2009·Nature Reviews. Cancer·Hui-Zi ChenGustavo Leone
Aug 26, 2010·Genes, Chromosomes & Cancer·Alexander B MohsenyAnne-Marie Cleton-Jansen

❮ Previous
Next ❯

Citations

Oct 16, 2014·Cancer Metastasis Reviews·Sung Sun Kim, Yong-Koo Park
Jul 7, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Andrew E HorvaiRichard J O'Donnell
Jun 22, 2017·BMC Veterinary Research·B G MurphyK Skorupski
May 18, 2021·Frontiers in Immunology·Jitian LiZhiping Guo
Aug 10, 2020·Current Medical Imaging·Francesco RicottaAchille Tarsitano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.